S&P・Nasdaq 本質的価値 お問い合わせ

Astrana Health, Inc. ASTH NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
56/100
3/7 Pass
SharesGrow Intrinsic Value
$42.41
+45.9%
Analyst Price Target
$32.75
+12.7%

Astrana Health, Inc. (ASTH) has 14 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp 6,132,802 株保有. その他の主要保有者には Sim Brandon および Sim Kenneth T..

過去12ヶ月間にインサイダーは 32 件の取引を実施 ASTH 株式 — 6 件の買い (評価額 RSU アワード) および 0 件の売り (評価額 RSU アワード). インサイダーの買いが売りを上回っており、会社の見通しに対する自信の表れかもしれません.

ASTH インサイダー保有状況

最大保有者
ALLIED PHYSICIANS OF CALIFORNIA, A PROFESSIONAL MEDICAL Corp
6,132,802 株
買い(12ヶ月)
6
$0.00 評価額
売り(12ヶ月)
0
$0.00 評価額
12ヶ月取引活動
買い 19%
売り 0%
インサイダー上位保有者
# 氏名 役職 保有株数 最終申告日 相対規模
1 Allied Physicians Of California, A Professional Medical Corp 10 Percent Owner 6,132,802 2025-02-18
100%
2 Sim Brandon CEO and President 1,023,219 2025-03-07
17%
3 Sim Kenneth T. Executive Chairman 546,349 2025-02-18
9%
4 Lam Thomas S. Director 423,990 2026-03-09
7%
5 Kumar Dinesh M. Chief Medical Officer 177,655 2026-04-03
3%
6 Basho Chandan COO and CFO 171,635 2026-04-03
3%
7 Marsh Linda Director 83,641 2025-06-13
1%
8 Chiang John Director 23,132 2025-06-13
0%
9 Vong John Chief Accounting Officer 17,520 2024-12-03
0%
10 Schmidt David Director 15,763 2025-06-13
0%
11 Mazdyasni Matthew Director 14,763 2025-06-13
0%
12 Sobotka Glenn Chief Accounting Officer 14,039 2026-03-30
0%
13 Dai, Weili Director 13,663 2025-06-13
0%
14 Kitayama Mitchell W Director 12,000 2025-09-15
0%
最近の取引 (過去12ヶ月)
日付 氏名 役職 種類 株数 株価 価値
2026-04-02 Basho Chandan COO and CFO RSU 源泉徴収 2,092 $25.05 $52.4K
2026-04-01 Kumar Dinesh M. Chief Medical Officer RSU 源泉徴収 57,980 $24.51 $1.42M
2026-03-26 Sobotka Glenn Chief Accounting Officer RSU 源泉徴収 662 $24.27 $16.07K
2026-03-05 Basho Chandan COO and CFO RSU 源泉徴収 1,240 $25.07 $31.09K
2026-03-05 Kumar Dinesh M. Chief Medical Officer RSU 源泉徴収 1,697 $25.07 $42.54K
2026-03-05 Lam Thomas S. Director RSU 源泉徴収 9,266 $25.07 $232.3K
2026-02-02 Sim Brandon CEO and President オプション行使(売却) 21,334 $23.24 $495.8K
2026-01-23 Kumar Dinesh M. Chief Medical Officer RSU 源泉徴収 10,759 $27.16 $292.21K
2026-01-13 Schmidt David Director オプション行使(売却) 20,000 $5.79 $115.8K
2026-01-01 Kumar Dinesh M. Chief Medical Officer RSU 源泉徴収 5,102 $24.81 $126.58K
2025-12-08 Lam Thomas S. Director オプション行使(売却) 29,502 $17.78 $524.55K
2025-11-10 Sim Kenneth T. Executive Chairman オプション行使(売却) 29,502 $17.78 $524.55K
2025-11-10 Mazdyasni Matthew Director オプション行使(売却) 20,000 $18.20 $364K
2025-11-07 Kitayama Mitchell W Director オプション行使(売却) 12,000 $18.20 $218.4K
2025-11-03 Marsh Linda Director オプション行使(売却) 20,000 $18.20 $364K
2025-10-02 Basho Chandan COO and CFO RSU 源泉徴収 1,979 $27.77 $54.96K
2025-09-15 Kitayama Mitchell W Director オプション行使(売却) 8,000 $18.20 $145.6K
2025-09-05 Basho Chandan COO and CFO RSU 源泉徴収 1,694 $29.70 $50.31K
2025-09-05 Kumar Dinesh M. Chief Medical Officer RSU 源泉徴収 1,694 $29.70 $50.31K
2025-09-02 Schmidt David Director オプション行使(売却) 20,000 $18.20 $364K
2025-08-13 Chiang John Director オプション行使(売却) 20,000 $18.20 $364K
2025-07-01 Kumar Dinesh M. Chief Medical Officer RSU 源泉徴収 6,831 $25.06 $171.18K
2025-06-11 Mazdyasni Matthew Director RSU 付与(制限付株式) 6,449 - -
2025-06-11 Chiang John Director RSU 付与(制限付株式) 6,449 - -
2025-06-11 Marsh Linda Director RSU 付与(制限付株式) 6,449 - -
お問い合わせ
🎓
SharesGrow アカデミー
本質的価値の計算と割安株の見つけ方を学ぶ。
毎週のライブセッション
メッセージを送る